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Foreword
This report aims to improve the assessment of mental health needs in the Americas by providing an updated and nuanced 
picture of: (a) the disability resulting from mental, substance use, and specific neurological disorders, plus self-harm, 
alone and in combination with premature mortality; (b) the imbalance between mental health spending and its related 
disease burden; and (c) the inadequate allocation of the meager mental health spending by countries of the Region.
Consistent with global trends, the epidemiologic transition in the Americas has resulted in a shift from communicable 
diseases, nutritional deficiencies, and maternal and child health conditions being the major causes of ill health and death, 
to noncommunicable diseases, which are responsible for increasingly higher levels of disability and premature mortality. 
A substantial proportion of the health problems in the Americas also arise from mental, neurological, and substance 
use disorders. Data show that people with mental disorders have high levels of disability as well as high mortality rates.
The Global Burden of Disease (GBD) approach is a systematic, scientific process to quantify the comparative magnitude 
of health lost due to diseases, injuries, and risk factors by age, sex and geography, for specific time periods. The GBD 
has had a profound impact on health policy as it is able to reveal the hidden burden of mental illness around the world.
The Burden of Mental Disorders in the Region of Americas, 2018 documents the latest available estimates of the burden of 
these conditions at the regional level. The data also reveal the consequences of these disorders in terms of lost health. 
Furthermore, this report provides data that demonstrate the limited resources within countries to adequately meet 
mental health needs, while underlining the often inequitable distribution and inefficient uses of such resources.
This report seeks to inform governments, civil society, and other stakeholders, and in so doing, raise the level of 
awareness about mental disorders in the Region, so as to mobilize political will and the necessary resources to combat 
mental, neurological, and substance use disorders and suicide in the Americas.
Dr. Anselm Hennis
Director
Department of Noncommunicable Diseases and Mental Health
Pan American Health Organization
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Main Findings 
zz Mental, substance use, and specific neurological disorders and suicide form a subgroup of diseases and conditions 
that are a major cause of disability and mortality, and give rise to a third of total years lived with disability (YLDs) and 
a fifth of total disability-adjusted life years (DALYs) in the Americas.
zz Depressive disorders are the largest cause of disability alone, and combined with mortality, account for 3.4% of total 
DALYs and 7.8% of total YLDs. 
zz The second largest subset comprises anxiety disorders, with 2.1% and 4.9%, respectively, of total DALYs and YLDs. 
Self-harm and somatoform disorders with prominent pain account, respectively, for 1.6% of DALYs and 4.7% of YLDs.
zz South America, in general, has higher proportions of disability due to common mental illness. Central America has 
a larger proportion of disability due to bipolar and childhood onset disorders, as well as due to epilepsy, than other 
subregions; and the USA and Canada suffer a high toll of disability from schizophrenia and dementia, as well as from 
devastating rates of opioid-use disorder.
zz The health system’s response to the challenge of mental illness shows a correlation with national income. Higher-
income countries spend a larger share of their health budgets on mental health services, and appear to allocate 
their spending more efficiently, away from neuropsychiatric hospitals and based on integration of mental health into 
primary care and community-based resources. Conversely, lower-income settings seem to compound their lack of 
resources by allocating them to specialized neuropsychiatric hospitals instead of funding community-based mental 
health services.
zz The imbalance between the percentage of the total burden caused by mental disorders, and the percentage of total 
health expenditures effectively allocated to mental health leads to the burden being three times the spending in the 
high-income countries to 435 times the spending in lowest-income country, with a regional median of 34.
zz Despite the constraints affecting mental health budgets in the Americas, there is significant potential to make 
meaningful improvements, while prioritizing the funding of community-based mental health services.
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Introduction
The global mental health field is rapidly evolving, particularly 
since the early 2000s, thanks to the collaboration of 
multilateral organizations, academic partners, patient 
and user advocates, and mental health workers. This 
joint effort yielded milestones such as the World Mental 
Health Report, the mhGAP program, the Lancet Global 
Mental Health series, the Mental Health Movement, and 
other initiatives that led to a better understanding of the 
disease burden of mental illness and of what the evidence-
based response to it should be (1–3). Mental illness is 
increasingly acknowledged as a global health priority, 
and given its economic burden it is also beginning to be 
considered a global development priority (4–6). Ultimately, 
this emergent prioritization led to its inclusion in the 
Sustainable Development Goals and to a global consensus 
that the drive for universal health coverage should be 
inclusive of mental health and well-being (7,8).
The epidemiologic transition is transforming the world: 
global health needs used to be determined by communicable 
diseases and early mortality, whereas now they are largely 
dominated by noncommunicable diseases (NCDs), multi-
morbidity, and survival with disability (9,10). Within this 
landscape, mental illness is proving to be a particularly 
complex challenge: despite its increasing visibility in the 
global health and development community, pervasive 
structural stigma, outdated frameworks and practices, and 
organizational fragmentation affect the ability to adequately 
assess, prioritize, invest in, and respond to mental illness in 
proportion to burden, in parity with physical health, and in 
keeping with effectiveness and cost-effectiveness evidence.
An adequate needs assessment is the cornerstone of 
prioritization, sound investment, and appropriate response, 
and traditional assessments of mental illness burden have 
methodological constraints that result in an underestimation 
of mental illness due mainly to five reasons: (i) the arbitrary 
separation between psychiatric and neurological disorders; 
(ii) the consideration of suicide and self-injurious behavior as 
a separate category outside mental illness; (iii) the conflation 
of painful somatoform disorders with musculoskeletal 
disorders; (iv) the exclusion of personality disorders; and (v) 
the inadequate consideration of the contribution of severe 
mental illness to mortality from associated causes.
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An additional caveat is the fact that the disease burden varies 
regionally and across time, so for burden estimations to be 
valid they need to be updated. It is a well-established fact 
that the disease burden profile differs between low-, middle-, 
and high-income countries; urban and rural populations; 
low- and high-income households; men and women; and 
across different age groups. Though it is not scientifically 
possible to address all these determinants simultaneously, 
each assessment of need must explicitly define its scope, 
and its validity limitations, both internal and external.
This report aims at improving the assessment of mental 
health needs in the Americas by providing an updated and 
nuanced picture of: (a) the disability resulting from mental, 
substance use, and specific neurological disorders, plus self-
harm, alone and in combination with premature mortality; 
(b) the imbalance between mental health spending and its 
related disease burden; and (c) the inadequate allocation of 
the meager mental health spending. The goal is to present:
1. A regional population-level view of mental disorders in the 
context of an overall health perspective, understanding 
how the disease burden varies between subregions and 
from country to country, particularly in relation to the 
other NCDs; to the communicable, maternal, nutritional, 
and neonatal conditions; and to injuries.
2. A detailed analysis of the burden related to mental, 
neurological, substance use, and suicide (MNSS) at 
the continental level and by country, specifying the 
percentage of the total disease burden that is due to 
the different mental disorders in terms of disability and 
combined with premature mortality.
3. A mapping of how the most relevant mental disorders 
are distributed across the Americas, considering how 
the different countries and subregions are affected.
4. An analysis of how government spending in mental 
health varies across the Americas in relation to national 
income, with a focus on mental health spending as a 
fraction of total government health spending, and on 
the percentage of mental health spending allocated to 
psychiatric hospitals.
5. Finally, simple and intuitive metrics are proposed in 
order to best assess the gap between disease burden 
and effective government spending on mental health.
Panel 1.  
Tree mapping. 
Throughout this report, tree maps will be used to convey 
multidimensional information in a single visualization. 
Tree maps display data through nested rectangles, with 
each rectangle having three dimensions: color, size, and 
position. 
The difference in colors within each tree map indicates 
the four PAHO subregions (Latin America, the Non-Latin 
Caribbean, South America, and Canada and the United 
States). Figure 5 shows each subregion in a different 
color, but the other tree maps in this report will use 
different shades of the same color to identify the four 
subregions, from lightest to darkest.
The difference in size reflects the quantitative difference 
between each country. Figure 5 shows the difference in 
the number of people, while the other tree maps reflect 
the different magnitude of the disease burden for each 
country.
The position depends on the size, with the largest 
rectangles on the upper-left corner and the smallest in 
the lower-right corner. It is useful to see all countries with 
a similar size—hence a similar disease burden—clustered 
together in the same region of the tree map.
So, at a glance we can see which countries have the 
largest and the smallest disease burden, by the size of 
the rectangles; whether countries belong to the same 
subregion, hence of the same color; whether countries 
share a similar burden or not, if they are clustered or 
dispersed in the graph; and whether there are sub-
regional gradients, indicated by the existence of well-
defined color clusters.
Each tree map will have a color cue and a brief description 
of its dimensions and what they represent.
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Since the publication in 1996 of the seminal work on the 
Global Burden of Disease (GBD), and through the sustained 
work by the World Health Organization and the Institute of 
Health Metrics and Evaluation, the disease burden metrics 
provide actionable, quantitative outcomes to measure 
and compare the disability and mortality that different 
illnesses impose upon individuals and communities (11–13). 
Estimating the local, national, and regional disease burden 
allows for rational disease prioritization, resource allocation, 
and health system planning—in conjunction with other 
criteria such as the broader social and economic burden, 
ethical considerations, and local resources or preferences.
In gathering and analyzing the data, it is important to 
understand the following three metrics: 
Disability-adjusted life years (DALYs) provide a 
composite measure of the mortality and disability 
attributable to any given illness. 
Years of life lost (YLLs) provide a measure of cause-
specific mortality weighted by life expectancy at time of 
death.
Years lived with disability (YLDs) provide a measure of 
a disease’s prevalence weighted by its disabling impact. 
We extracted 2015 disaggregated data (country-age- 
sex-specific absolute numbers, rates, and percentages) 
from the Global Health Data Exchange for all disease causes 
and countries in the Americas, and re-estimated the disease 
burden for MNSS following the framework described by 
Vigo et al., which includes: (a) self-harm-related disability 
and mortality; (b) neurological conditions with prominent 
mental and behavioral syndromes that present frequently 
at the primary care level (dementia, epilepsy, migraine, 
and tension-type headache); and (c) a fraction of pain 
syndromes without anatomic correlation, corresponding to 
an estimation for DSM-5 somatic symptom disorder with 
Disease burden distribution in the Americas
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Noncommunicable diseases Injuries
MNSS
Communicable, 
mother, child
and nutritional 
disorders
59% 19% 12%
10%
Figure 1: Regional disability-adjusted life years (DALYs) distribution tree map (%)
prominent pain and ICD-10 somatization disorders, which 
frequently constitute a presentation of mood, anxiety, and 
personality disorders, particularly in contexts of high stigma 
towards common mental illness (12,13,15,16).
Regional disability and 
mortality: disability-adjusted 
life years (DALYs)
Globally, NCDs accounted for 60% of total DALYs in 2015, 
of which 12% corresponded to MNSS. Meanwhile in the 
Americas, NCDs accounted for a much larger 78% of total 
DALYs, with MNSS taking up a much larger fraction of DALYs 
at 19%. The remaining 59% of NCD DALYs are distributed 
among cardiovascular disease; cancer; musculoskeletal 
disorders; diabetes; neurologic, respiratory, digestive, 
urinary, gynecologic disorders, and others. Finally, 
communicable, maternal, child, and nutritional disorders 
are responsible for 12%, and injuries for 10% of total DALYs. 
This distribution highlights the fact that MNSS comprise 
nearly a fifth of total DALYs, constituting the largest 
subgroup cause of disease burden in terms of disability 
and mortality combined, even larger than two higher level 
groupings: injuries and communicable, maternal, child, 
and nutritional disorders. 
Figure 1 shows the three groups of disorders (NCDs; 
communicable, maternal, child, and nutritional disorders; 
and injuries) with MNSS as a separate subgroup of NCDs. 
The largest mental cause of DALYs is depressive disorders, 
which account for 3.4% of total DALYs, followed by anxiety 
disorders with 2.1%. A regional ranking of specific mental 
disorder DALYs is available in Figure 2.
Regional disability: years lived 
with disability (YLDs) 
Mortality data do not adequately capture the deaths 
caused by mental illness; therefore, it is useful to 
compare disability separately, as measured by YLDs. 
This metric is not affected by the exclusion of mental 
illness deaths and provides a valid comparison across 
5The Burden of Mental Disorders in the Region of the Americas, 2018
Figure 2: Ranking of mental, neurological, and substance use disorders, and suicide DALYs
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0.49%
0.32%
0.13%
0.12%
0.10%
0.04%
disease groupings. Our analysis shows that MNSS 
account for more than a third of total disability in the 
Americas: 34% of total YLDs. 
All the other NCD sub-groups combined account for an 
additional 54% of YLDs; communicable, maternal, child and 
nutritional for 8% of disability; and injuries for 4%, making 
MNSS by far the largest subgroup (Figure 3). Figure 4 
shows a regional ranking of YLDs attributable to MNSS.
Country-level analysis
In order to complement the regional analysis, a by-country 
study of the disease burden of mental disorders was 
conducted. This detailed country-level grounding of the 
data is important because of two main reasons:
(a) The Americas comprise a vast number of countries 
and territories—36 of which have been included in this 
report—of very dissimilar population numbers. Figure 5 
shows a tree map of all countries grouped by subregions, 
with the size of each square reflecting the population 
size. It is clearly seen that three countries—the United 
States, Brazil, and Mexico—comprise two-thirds of the 
billion people living in the Americas, so the aggregated 
regional disease burden will be highly determined by the 
disease profile of these three countries. Furthermore, 
an exclusively regional perspective would obscure the 
disease burden of the Non-Latin Caribbean, given their 
comparatively small populations (the green fraction of 
Figure 5). Besides the country-specific percentages, 
average country-level percentages will be provided when 
meaningfully different from the regional aggregate.
(b) The goal of this report is to provide an actionable 
needs assessment that can inform mental health 
prioritization, system planning, and service delivery at 
the country level, so it is with national-level decision-
makers in mind that this report has been conceived. 
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Figure 3: Regional years lived with disability (YLD) distribution (%)
Noncommunicable diseases Injuries
MNSS
Communicable, maternal, 
child and nutritional disorders
54% 34%
8% 4%
Figure 4: Ranking of mental, neurological, and substance use disorders, and suicide years lived with disability (YLDs)
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Country-level disability and 
mortality (DALYs)
There is significant heterogeneity in the distribution of the 
main causes of disability combined with mortality in the 
Americas. DALYs caused by NCDs, including mental illness, 
are the largest fraction of total burden in every country in 
the Region of the Americas, ranging from 50% in Haiti to 
89% of total burden in Canada. The second regional cause-
group of DALYs, comprising communicable, maternal, child, 
and nutritional disorders, ranges between 5.5% in Canada 
and the United States and 39% in Haiti. The third regional 
cause of DALYs is the group of injuries, which ranges from 
6% in Canada, Cuba, Barbados and Bermuda, to 20% in El 
Salvador. Figure 6 highlights that NCDs remain the largest 
cause of disability and mortality combined across countries 
despite large individual variations, whereas the group of 
communicable, maternal, child, and nutritional disorders 
and the group of injuries alternate in the second and third 
rank-order, with a primacy of the former, especially in lower-
income countries. The subgroup of MNSS also shows large 
between-country variation, ranging from 9% of total DALYs 
in Haiti to 23% in Canada (see Figure 6).
Country-level disability (YLDs)
An analysis of years lived with disability (YLDs) provides 
a picture that (a) complements the DALY burden analysis 
and (b) is not biased by the differential exclusion of excess 
mortality resulting from mental illness. The between-
country variation of YLDs as a percentage of total disability 
is much lower than the DALY variation discussed in the 
Figure 5: Population distribution of the countries in the Americas
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Figure 6: Disability-adjusted life years (DALYs) distribution by country (%)
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Figure 7: Years lived with disability (YLDs) by country (% of total YLDs)
MNSS
Noncommunicable diseases
Injuries
Communicable, maternal, neonatal, and nutritional diseases
Brazil
Chile
Paraguay
Peru
Colombia
Nicaragua
Costa Rica
Argentina
Honduras
Mexico
United States
Ecuador
Belize
Antigua and Barbuda
Bermuda
Dominican Republic
Uruguay
Canada
Suriname
Panama
Bolivia
Saint Lucia
Saint Vincent and the Grenadines
Grenada
Guatemala
El Salvador
Cuba
Puerto Rico
Dominica
Jamaica
Trinidad and Tobago
Guyana
Barbados
Virgin Islands, U.S.
Venezuela
Haiti
0% 20%10% 40%30% 60%50% 80% 90%70% 100%
36%
36%
36%
35%
35%
35%
34%
34%
34%
33%
33%
33%
33%
33%
33%
33%
33%
33%
32%
32%
32%
32%
32%
32%
32%
32%
32%
31%
31%
31%
31%
31%
30%
30%
29%
28%
10 The Burden of Mental Disorders in the Region of the Americas, 2018
Figure 8: Mental, neurological and substance use disorders and suicide disability tree map (YLDs by country as a percentage 
of total disability)
Tree map dimensions: the color indicates the subregion and the size of each rectangle reflects the magnitude of the burden. Countries with similar 
burdens are clustered together in the same region of the tree map.
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previous section (except for disaster-related disability in 
Haiti, which drives YLDs caused by injuries up to 10% of 
total). The overall variation of NCD disability ranges from 
70% of total YLDs in Haiti to 91% in Mexico. Focusing on 
mental illness, the variation ranges between 28% in Haiti 
to 36% in Brazil, Chile, and Paraguay. Communicable, 
maternal, child, and nutritional disorders range from 5% 
of YLDs in the United States and Chile to 20% of YLDs in 
Venezuela and Haiti (see Figure 7).
 
Figure 7 shows that disability resulting from MNSS is 
remarkably similar (and high) throughout the region. 
MNSS constitute indisputably, and by a wide margin, 
the largest subgroup cause of disability in every country, 
regardless of income level or subregion. There appears 
to be a subregional gradient in the disability resulting 
from aggregated MNSS (see Figure 8), with South 
American countries occupying the top five positions in 
terms of YLDs, with most countries above the country-
average (33%) and regional aggregate (34%) disability. 
As we will see in the disorder-specific sections, there 
is a wide variation across countries in terms of which 
specific mental disorders cause the largest burden. It is 
important for decision-makers to consider the specific 
disease profile that affects their country to adequately 
prioritize conditions, allocate investments, and plan 
11The Burden of Mental Disorders in the Region of the Americas, 2018
service delivery. 
Common mental disorders
Common mental disorders generally comprise depressive 
and anxiety disorders. It is necessary to point out, 
however, that a number of other very common mental 
and behavioral syndromes are not considered in typical 
burden of disease calculations and analyses, despite their 
significant prevalence, disability, and mortality (15,19). Of 
note, personality disorders and somatic symptom disorders 
are excluded due to the lack of consistent cross-country 
data, and self-harm and suicide are considered under the 
heading of injuries, despite the well-established fact that 
mental disorders and sub-threshold syndromes are largely 
responsible for intentional self-harm (15,20). The result 
is that somatoform disorders with predominant pain—a 
psychiatric disorder formerly known as pain disorder, which 
when properly studied emerges as the single most prevalent 
mental disorder, affecting 8% of the general population 
yearly (21)—is systematically and erroneously conflated 
with musculoskeletal disorders, leading to inflation of that 
category despite the absence of a causal link of these 
syndromes to the musculoskeletal system (15,22). Similarly, 
personality disorders—a group of behavioral and mental 
syndromes frequently comprising problematic interpersonal 
functioning, affective and cognitive symptoms, impulsivity, 
self-harm, and somatic complaints—are not considered at 
all in burden of disease calculations despite the fact that 
they are highly prevalent (4 to 15% in community surveys) 
(23). Following the method described in detail elsewhere 
(15), this study includes self-harm and an estimation for 
pain disorders, thus indirectly capturing a fraction of the 
disability resulting from personality disorders and the 
excess death from depression and other mental illnesses 
due to suicide. Given the high prevalence of these mental 
Disability resulting from specific disorders
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and behavioral syndromes, they are considered in this 
section of common mental illness.
  Depressive disorders
For the purpose of the current analysis, depressive 
disorders comprise depressive disorder and dysthymic 
disorder. Depressive disorder can be a highly disabling 
condition, as reflected by its disability weight in the 
burden of disease framework. Severe depressive 
episodes are considered, based on surveys of the 
general population, to be the fifth-most disabling human 
health state, after acute schizophrenia, untreated neck-
level spinal cord lesion, severe multiple sclerosis, and 
severe heroin dependence (24). Even mild depressive 
disorders and dysthymia are considered highly disabling, 
at the same level of, for example, severe anemia or 
uncontrolled asthma. The disability resulting from 
depressive disorders, both at the individual and at the 
population level can be considered as a continuum of 
health states from moderately to severely disabling.
Figure 9: Depressive disorder disability tree map (YLDs by country as a percentage of total disability)
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At the regional level, this analysis places depression at 
the top of disability causes, with 7.8% of total disability, 
and a range from 5.9% in Canada to 9.4% in Paraguay. A 
subregional pattern of increased disability in South America 
is evident, as indicated by the following: (a) Paraguay, Brazil, 
Peru, Ecuador, and Colombia constituting the top five in 
the depression disability ranking; and (b) a clear majority 
of South American countries at or above the country- 
average (7.7%) and regional aggregate (7.8%) (see Figure 
9). Another important aspect of depressive disorders 
is that they affects mainly the young: nearly 10 million 
of the 14.5 million depression YLDs in the Americas fall 
within the 15- to 50-year-old age group (see Figure 10).
  Anxiety disorders
This group of disorders comprises many syndromes 
characterized by prominent anxiety, such as generalized 
anxiety disorder, panic disorder, social anxiety disorder, 
and others. From a disability perspective, they can range 
from severely disabling to mildly troublesome, and for 
Figure 10: Depressive disorder: years lived with disability by age groups (total of YLDs)
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our 2015 data analysis we consider them aggregated, 
including post-traumatic stress disorder and obsessive-
compulsive disorders.
Anxiety disorder is the second-most disabling mental 
disorder in most countries of the Americas. A subregional 
pattern is even more discernible than for depressive 
disorders, with Brazil at the top (7.5%); all but one South 
American country showing above country-average (4.7%) 
and regional aggregate (4.9%) disability; and 8 of the 
top 10 countries in terms of disability corresponding to 
this subregion (see Figure 11). North America falls at the 
other end of the spectrum, with Canada showing the least 
disability (3.4%), followed by Mexico (3.6%) and the USA 
(4.1%) also well below the regional average and aggregate.
  Self-harm and suicide
Given the well-established relationship of common mental 
illnesses (such as depressive and personality disorders) 
with suicide and self-harm, these illnesses are considered 
in this section. The burden of disease framework does not 
include personality disorders, a well-established cause of 
non-lethal self-harm (23,27), and YLDs resulting from self-
Figure 11: Anxiety disorders disability tree map (YLDs by country as a percentage of total disability)
Tree map dimensions: the color indicates the subregion and the size of each rectangle reflects the magnitude of the burden. Countries with similar 
burdens are clustered together in the same region of the tree map.
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Figure 12: Suicide and self-harm burden tree map (DALYs by country as a percentage of total disability)
harm are not captured in the burden of disease framework. 
Therefore, this section will focus on suicide DALYs, which 
are largely due to years of life lost due to premature death.
Suicide is the fifth highest cause of DALYs in the Americas, 
with an almost nine-fold range in terms of percentage of 
total burden, from 0.4% in Antigua and Barbuda to 3.6% 
in Suriname. There is a remarkable subregional pattern 
affecting Suriname (3.6%), Guyana (3.5%), and, to a lesser 
extent, nearby Trinidad and Tobago (2.1%); as well as Uruguay 
(2.6%), Chile (2.5%), and Argentina (2%) in South America. 
The United States (2.2%) plus Canada (2.1%) also comprise 
subregional clusters affected by suicide well in excess of the 
country-average (1.5%) and aggregate (1.6%) percentages 
(see Figure 12). The toll that suicide takes in the Americas 
is daunting, and it falls mainly on younger working-age 
populations: 60% of the nearly 100,000 suicides occurred 
between 15 and 50 years of age; 4,129,576 years of life 
were lost, of which around 75% were lost by this same age 
group (see Figure 13). 
 
  Somatoform disorders/persistent 
somatoform pain disorder
Somatoform disorders with predominant pain are poorly 
understood syndromes and thereby frequently ignored 
by clinicians, psychiatrists, and epidemiologists (22,28). 
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When properly studied, however, they are highly prevalent, 
especially in women: the 12-month prevalence of DSM-IV 
pain disorder has been established by one study as 11% 
for females and 4% for males, with an overall rate of 8%, 
the largest for any mental disorder (21). Some 56% of pain 
disorder patients meet the criteria for another psychiatric 
disorder, most frequently depressive or anxiety disorders. 
The prevalence of painful syndromes in patients diagnosed 
with depressive or anxiety disorders has been found 
to be greater than 30%, and up to 80% in specific post-
traumatic stress disorder populations (29). Routine burden 
of disease assessments assign 0% of the burden of painful 
syndromes to mental disorders, an assumption lacking 
minimal face validity. Reattributing a fraction of this burden 
to MNSS as described elsewhere yields an estimate of 
4.7% of total YLDs due to somatic symptom disorder with 
prominent pain (15). The estimated range is between 6.2% 
in Canada and 3.2% in Haiti, and higher-income countries 
seem to be more affected than lower-income countries. 
These estimates should be considered indicative until 
Figure 13: Total years of life lost by age group*
*Columns represent total YLLs in the Americas for four separate age groups, and a fifth column for all ages.
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primary data on somatoform disorders disability become 
available. Of note, the importance of this issue has led 
to the recent creation of a specific section to screen for 
somatic symptom disorders in the WHO World Mental 
Health Composite International Diagnostic Interview, to 
be administered in future World Mental Health Surveys, 
filling this gap.
Severe mental disorders
Schizophrenia and bipolar disorders are usually referred to 
as severe mental disorders. Indeed, they exact some of the 
largest tolls conceivable on human beings: acute psychotic 
episodes in the context of schizophrenia are considered 
the most disabling health state in the burden of disease 
framework (24); manic episodes are highly disabling 
medical emergencies, frequently leading to socioeconomic 
ruin, injury, or death if untreated; and depressive episodes 
in the context of bipolar illness can be as severe as those 
of depressive disorder, particularly in the context of bipolar 
disorder type II. Severe mental illness is particularly lethal 
in low-income settings, which tend to also be contexts of 
high stigma. The increased lethality is due to the lack of 
effective mental care and to inadequate general medical 
care for people with severe mental disorders, which lead to 
largely preventable excess mortality. The lack of effective, 
accessible, or even available services, coupled with the 
catastrophic economic and emotional burden on families, 
frequently lead to systematic human rights abuses in 
lieu of treatment, resulting in what has been memorably 
labeled a “failure of humanity” (30). Indeed, as detailed in 
the section devoted to the health system response, lower 
country income is associated with decreased availability of 
services, worse services when available, and earlier death 
for severe mental illness.
  Schizophrenia
In the burden of disease framework, the schizophrenias 
are considered the most disabling human disorders, 
particularly during acute episodes. 
The regional variation of schizophrenia disability as 
a percentage of total disability ranges between 1.1% 
in Haiti and 2.5% in the United States (see Figure 14). 
Subregional patterns are less clear, but the USA, Canada, 
and most South American countries are above the 
country average (1.6%). Several factors could explain an 
increasing share of the disability as income level grows, 
most notably increased premature mortality and/or 
decreased case-detection capacity in poor settings. 
Research has shown that people with schizophrenia 
die between 10 and 30 years younger than their peers, 
with the worst outcomes seen in low-income countries 
(17,31), which would explain the decreasing share of the 
resulting survival with disability.
  Bipolar disorders
Bipolar disorders are the cause of significant disability and 
mortality in the Americas. Clinical presentation is highly 
variable both across and within cases: some episodes 
constitute mild or moderate fluctuations in mood that are 
compatible with a high functionality and quality of life, while 
others evolve into severe depressive or manic episodes, 
the former of which can lead to suicide, and the latter, as 
mentioned before, to death, disability, or socioeconomic 
ruin if untreated. So, unlike the uniformly high disability 
resulting from schizophrenia, disability resulting from bipolar 
disorders can range from mild dysfunction during residual 
states to almost complete impairment during severe manic 
and depressive episodes. For the purposes of our analysis, 
bipolar disorders comprise types I and II, characterized 
by manic and hypomanic episodes, respectively. The 
latter constitutes a milder and shorter behavioral and 
psychological activation syndrome than the former.
A subregional pattern seems to emerge for bipolar disorder 
disability: every country in continental Central America is 
above the country-average and regional aggregate of 1.4% 
(see Figure 15), while both Canada and the United States 
are below the aggregate (1.3% and 1.2%, respectively). The 
range is between 1.1% of total YLDs in the Virgin Islands to 
1.7% in Nicaragua.
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Substance use and eating 
disorders
Disorders stemming from the use of substances (alcohol, 
drugs, or food) are frequently considered together due to their 
similar clinical pattern, mostly related to their compulsive 
nature and the direct behavioral dysfunction they entail. This 
makes them different from smoking, which entails mostly 
indirect disability through its physical consequences. The 
current analysis focuses on alcohol use disorder, substance 
use disorders, and eating disorders. These disorders include 
varying severities that range from the low impairment of mild 
cannabis use disorder to the almost total disability resulting 
from severe heroin dependence, and including the moderate 
disability resulting from anorexia and bulimia.
  Disorders due to use of alcohol
The disability resulting from alcohol use disorders 
ranges from 0.5% in Paraguay to 1.9% in Guatemala 
and El Salvador. It presents a subregional pattern with 
the United States, Canada, and most South American 
Figure 14: Schizophrenia disability tree map (YLDs by country as a percentage of total disability)  
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countries well below the country average of 1.2% (only 
Chile exceeds it at 1.5%), and at or below the regional 
aggregate (0.9%). Meanwhile, every country in Central 
America and the Caribbean is above the regional 
aggregate, and most are above the country average (see 
Figure 16).
It should be noted that Figure 16 represents years lived 
with disability (YLDs), but alcohol use disorders also 
impose a significant burden in terms of years of life lost 
(YLLs), both directly and through excess death due to 
cardiomyopathy, liver cancer, and cirrhosis.
  Disorders due to substance use
(not alcohol)
We consider here together cannabis, cocaine, 
amphetamine, and opioid use disorders. The variation 
in disability burden resulting from drug use ranges from 
0.5% in Barbados and 0.6% in Haiti and Cuba, to 3.1% in 
Figure 15: Bipolar affective disorder disability tree map (YLDs by country as a percentage of total disability)
Tree map dimensions: the color indicates the subregion and the size of each rectangle reflects the magnitude of the burden. Countries with similar 
burdens are clustered together in the same region of the tree map.
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the United States (see Figure 17). This six-fold variation 
reflects the raging epidemic of opioid use disorders 
affecting the United States and Canada (2.5%); in both 
of which, the specific burden of opioid use disorders 
constitutes around 70% of all drug use disability.
As is the case with alcohol, other substance use 
disorders cause a significant number of years of life lost 
across the region, but most notably in the United States 
and Canada, where they produced 1.73% and 0.92% of 
total years of life lost, respectively.
  Eating disorders
Anorexia and bulimia together account for a comparably 
much smaller fraction of total burden; between 0.07% 
in Haiti and 0.42% in the United States. Only the United 
States and Canada are above the regional aggregate 
percentage of 0.3%, indicating that the burden of eating 
disorders falls mostly on well-off countries. 
Figure 16: Disorders due to use of alcohol disability tree map (YLDs by country as a percentage of total disability)
Tree map dimensions: the color indicates the subregion and the size of each rectangle reflects the magnitude of the burden. Countries with similar 
burdens are clustered together in the same region of the tree map.
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Disorders with onset usually 
occurring in childhood and 
adolescence
Collectively, disorders that affect mainly children and 
adolescents account for 2.2% of total YLDs in America. 
They include, in order of importance, autism (1.2%), 
conduct disorders (0.7%), intellectual disability (0.2%), 
and attention-deficit and hyperactivity disorder (0.1%). 
They show a clear subregional pattern, with all continental 
Central American countries and all South American 
countries above the regional aggregate percentage. 
Conversely, most of the English-speaking Caribbean 
islands, the United States, and Canada (1.8% in both) show 
the lowest burden (see Figure 18).
Figure 17: Disorders due to substance use (not alcohol) disability tree map (YLDs by country as a percentage of 
total disability)
Tree map dimensions: the color indicates the subregion and the size of each rectangle reflects the magnitude of the burden. Countries with similar 
burdens are clustered together in the same region of the tree map.
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Neurological disorders
This category includes the disability resulting from 
neurocognitive disorders—such as Alzheimer’s disease, 
epilepsy, migraine, and tension-type headache, all of 
which have prominent mental and behavioral syndromes.
  Neurocognitive disorders
Alzheimer’s and other dementias account for 1.2% of total 
disability, ranging from 0.4% in Haiti to 1.9% in Canada. 
They reflect a highly significant trend, correlating higher 
GDP with a higher percentage of total disability attributable 
to the dementias. This is an expression of the demographic 
change in age structure, where increased survival, and 
disability resulting from the disorders of older adults, 
accompanies economic development (see Figure 19).
  Epilepsy
Epilepsy is responsible for 0.8% of total disability in 
the region, ranging between 0.2% in Canada and 1.6% 
in Honduras. Subregionally, epilepsy produces a lower 
percentage of disability in Canada and the United 
Figure 18: Disorders with onset usually occurring in childhood and adolescence disability tree map
Tree map dimensions: the color indicates the subregion and the size of each rectangle reflects the magnitude of the burden. Countries with similar 
burdens are clustered together in the same region of the tree map.
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States, and a larger proportion in Honduras, Guatemala, 
and Mexico. In fact, most countries in Central America, 
South America, and the Caribbean are above the regional 
aggregate percentage (see Figure 20).
  Migraine and tension-type headaches
Migraines account for 4.4% of the regional disability 
burden, ranging from 3.6% in the United States (3.6%) 
to 5.4% in Peru. Tension-type headaches produce a 
comparatively lower regional burden (0.3%), and there 
does not appear to be a subregional pattern for either 
condition. However, the significant burden of headache-
related disability and its potential implications for health 
systems–namely, the need for widespread training of 
primary care workers in their detection and management—
have only recently come to the fore.
Figure 19: Dementia disability tree map
Tree map dimensions: the color indicates the subregion and the size of each rectangle reflects the magnitude of the burden. Countries with similar 
burden are clustered together in the same region of the tree map.
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Tree map dimensions: the color indicates the subregion and the size of each rectangle reflects the magnitude of the burden. Countries with similar 
burden are clustered together in the same region of the tree map.
Figure 20: Epilepsy disability tree map
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This section will focus on how our societies respond 
to the challenge presented by the MNSS. In so doing, 
this study will analyze how investment in mental health 
services and allocation of spending vary as a function of 
national income. As a result, simple intuitive metrics are 
presented that allow for comparison of the gap between 
burden and spending across countries. 
The present analysis is based on a set of estimates of 
health spending and allocation obtained by collating the 
latest available data reported to PAHO by governments 
of the Americas and published in the WHO Assessment 
Instrument for Mental Health Systems (WHO-AIMS). This 
was supplemented with additional published data when 
missing, or when more recent WHO-AIMS country-level 
data were available (range: 2009-2015). For countries 
or territories with unavailable data for mental health 
spending or for fraction spent on mental hospitals, we 
imputed the median regional value. We excluded countries 
missing both data points, as well as territories without 
burden of disease data. We also obtained 2015 real 
per-capita GDP from the International Monetary Fund’s 
World Economic Outlook Database. For the British Virgin 
Islands we imputed the subregional median for the Non-
Latin Caribbean territories. A limitation to the following 
analysis emerges from the fact that these data are self-
Health system response in the Americas: 
Government funding for mental health 
services
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reported by ministries of health to WHO, and its quality 
is variable due to lack of unified reporting criteria about 
which types of expenditures are included or excluded. 
For example, potentially significant resources allocated 
to dementia care or suicide prevention, or services 
delivered through the non-health sectors are probably not 
captured in these estimates. However, even considering 
these limitations, it is unlikely that inconsistencies in the 
inclusion of dementia, suicide prevention, or non-health 
sector expenditures would decrease the imbalance found 
in low-income countries. In fact, it is actually more likely 
that these expenditures would be much higher in high-
income countries, thus increasing the strength of the 
inverse correlation shown here. Therefore, the following 
findings about the imbalance between the burden and the 
spending on mental health services can be considered 
conservative.
Mental health spending as a 
percentage of government 
health spending
Median spending in mental health services stands 
globally at 2.8% of total government health spending, 
despite the fact that mental disorders account for 12% of 
total DALYs and 35% of total YLDs. Low-income countries 
spend around 0.5% of their health budget in mental 
health services, and high-income countries, 5.1% (15). 
In the Americas, spending ranges from 0.2% in Bolivia 
to 8.6% reported by Suriname.  There is a significant 
direct linear correlation between national income and 
Government spending in mental health as a proportion 
of the total health budget (see Figure 21).
WHO recommends that health spending allocation should 
be in proportion to the health burden, and that there 
should be parity between physical and mental aspects of 
health care (32,33). In practical terms, this means that 
physical and mental health services should be provided 
in an integrated manner, and that the percentage of 
spending allocated to mental health services should 
be proportionate to the percentage of its attributable 
burden. There are several challenges to operationalizing 
these concepts: (a) as noted earlier, the DALY burden for 
mental disorders is usually underestimated due to lack of 
registration of deaths due to most mental illnesses. YLDs 
would provide a less biased comparator for disability 
across diseases, because disability is adequately 
registered for all disorders through prevalence estimates. 
However, since YLDs do not include mortality, they 
would not be appropriate as the only measure of overall 
burden. Also, (b) reporting mental health expenditures 
as a specific percentage of total government health 
spending is inconsistent across countries due to the 
lack of a unified reporting strategy (e.g. which types 
of services are included or excluded, how to estimate 
services delivered through other sectors, etc.). Moreover, 
it does not account for private spending, which in many 
countries is the main source of mental health funding. 
Despite these caveats, a simple measure is provided of 
mental health spending gap resulting from dividing the 
percentage of total DALYs attributable to MNSS by the 
percentage of the government health budget allocated to 
mental health services. A ratio of 1 would entail equality 
between the proportions of disease burden and spending, 
implying the assumption of equivalent cost-effectiveness 
of interventions across health sectors, which would not 
be based on current evidence. 
Figure 22 shows all countries ordered by the ratio of mental 
illness burden to expenditure on mental health. A wide 
regional variation is evident, ranging from a burden that is 1.8 
to 72 times the reported spending. The median for countries 
of the Americas is 6.1, indicating that the proportion of 
burden attributable to mental disorders is 6 times the 
proportion of health funds allocated to mental health.
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Mental health spending 
allocation
The previous analysis, however, does not take into account 
allocation of spending within the mental health subsystem. 
International guidelines and evidence indicate that services 
for mental disorders should aim at caring for people in the 
community, providing integrated services for mental illness in 
primary care or general hospitals, and community treatment 
plus social support for severely affected individuals (33). 
The fraction of mental health spending that is not allocated 
to neuropsychiatric hospitals can be considered a proxy 
for how well allocated mental health spending is, since 
asylums lack any evidence of effectiveness, are notoriously 
inefficient, and can in fact lead to iatrogenic practices. 
Despite some outliers, a linear trend model correlating the 
natural logarithm of the percentage of the mental health 
budget allocated to neuropsychiatric hospitals and 2015 
GDP is highly significant (see Figure 23).
The figure suggests that higher income countries not 
only spend a larger proportion of their health budget on 
Figure 21: Mental health spending vs. per-capita GDP (PPP)*
*Linear model: ln (% of health expenditures spent on MNSS) = 0.68*ln (GDP) + -5.6. R2:0.26. p=0.0036. Confidence bands show upper and lower 
95% confidence lines.
MNSS: Mental, neurological, substance use disorders and self-harm
GDP (PPP): gross domestic product, purchasing-power parity adjusted
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Figure 22: Ratio of % of total DALYs attributable to MNSS to % of health spending allocated to mental health, ordered 
from smallest to largest
MNSS: Mental, neurological, substance use disorders and self-harm
m indicates the regional median value
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mental health services, but also potentially allocate that 
increasing proportion better, to mental health services that 
are evidence-based and follow international guidelines, 
providing integrated treatment in general health services 
and community support. This community-based approach 
is respectful of the social and human rights of patients, as 
opposed to asylum-based segregationist approaches that 
foster isolation and potentially human rights violations. 
In order to visualize the magnitude of the imbalance in 
spending, and considering the mental burden that should 
be managed in the community over the spending not 
absorbed by neuropsychiatric hospitals, a very different 
ordering can be obtained (compare Figures 22 and 
24).1 It is clear that in terms of percentage of burden 
over percentage of spending efficiently allocated, the 
imbalance varies by two orders of magnitude: from the 
burden being three times the spending in the USA and 
Canada to 435 times the spending in Haiti. The regional 
median indicates an imbalance between mental health 
burden and spending of 31.5 to 1. What this metric 
indicates is that there is a gap in spending associated 
1  This study subtracted from the numerator the percentage of burden attributable to the most severe health state associated with schizophrenia 
(69%), assuming that neuropsychiatric hospitals would be adequately suited to treat this fraction of the most severely affected. From the 
denominator, this study subtracted the fraction of spending allocated to neuropsychiatric hospitals.
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with country-level income, disproportionately affecting 
lower-income countries.
This gap likely results in (a) an increasing treatment 
gap for poorer countries and (b) increased private 
spending in mental health services, particularly out-of-
pocket expenses. For example, the 3 to 1 imbalance 
documented in Canada and the United States results in 
undertreatment, which a recent study estimated to be 
5 to 1 for depressive disorder in high-income countries. 
As such, only 22.4% received minimally adequate 
treatment in high-income countries, and specifically 
26% in the United States  (34). In low- or lower-middle 
income countries, the ratio was estimated at 27 to 1, 
with only 4.7% of people in need receiving minimally 
adequate services. Specifically, it was found that in Peru, 
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Figure 23: MNSS spending allocated to mental hospitals vs. GDP (PPP)1
*Linear model: Ln (% MNSS expenditures spent on mental hospitals) = -050*ln(GDP) + 8.9. R2=0.32.  p=0.0012. Confidence bands show upper and 
lower 95% confidence lines.
MNSS: Mental, neurological, substance use disorders and self-harm
GDP (PPP): gross domestic product, purchasing-power parity adjusted
1 Figures 21 and 23 raise the possibility that Haiti, Canada, and the United States may be outliers and influence our results. Hence, we re-ran the 
analyses excluding Haiti, Canada, and the US for both models. The results and their significance hold for the model correlating the fraction of overall 
health expenditures spent on mental health with GDP (with a p value <0.05) but lose significance for the model correlating the fraction spent on 
mental hospitals with GDP.
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Figure 24: Imbalance in spending: ratio of MNSS burden to efficiently allocated spending * 
MNSS: Mental, neurological, substance use disorders and self-harm
m indicates the regional median value 
* This ratio excludes from the nominator the percent of burden attributable to the most severe form of schizophrenia, and from the denominator 
the percent allocated to neuropsychiatric hospitals: (mental disorders as % of total DALYs–63% of schizophrenia DALYs)/(% health budget–% spent 
on neuropsychiatric hospitals). The GBD model estimates that 63% of prevalent cases correspond to acute schizophrenia, which carries a disability 
weight of 0.778. Meanwhile, 37% of prevalent cases correspond to residual schizophrenia, carrying a disability weight of 0.588 (disability weights 
range from 0, perfect health, to 1, equivalent to death). As YLLs for schizophrenia are negligible and YLDs result from multiplying prevalent cases 
by disability weight, it was estimated that 69% of the disease burden of schizophrenia is attributable to the acute state.
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one person received minimally adequate treatment for 
every 100 persons with a valid diagnosis of depressive 
disorder. These numbers are consistent with the findings 
presented herein: (a) the United States and Canada show 
the lowest imbalance and (b) Peru has one of the largest 
gaps in the continent, with a 313-fold imbalance in burden 
relative to government spending. These findings merit 
further study, for example, about whether the imbalance 
found is partly closed by private spending, leading to 
the 100 to 0.9 undertreatment found by Thornicroft et 
al., which in low-income countries would mean mostly 
out-of-pocket spending, piling potentially catastrophic 
economic burden upon the disease burden (34).
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Conclusion
MNSS is a group of diseases and conditions that constitute 
a major cause of disability and mortality, and give rise 
to a third of total YLDs and a fifth of total DALYs in the 
Americas. Of the mental disorders, depressive disorders 
are the largest cause of disability alone, and combined 
with mortality, accounting for 3.4% of total DALYs and 
7.8% of total YLDs. The second largest subset comprises 
anxiety disorders, with 2.1% and 4.9%, respectively, of total 
DALYs and YLDs. Self-harm and somatoform disorders 
with prominent pain should also be considered common 
mental disorders, accountable respectively for 1.6% of 
DALYs and 4.7% of YLDs. Severe mental illness leads to 
increased mortality, particularly in low-income settings, 
with high-income countries thus coping with an increased 
share of the disability burden due to schizophrenia. Several 
subregional patterns emerge in the distribution of specific 
mental disorders, and this report provides decision-
makers with a nuanced picture of mental disorders in most 
countries or territories of the Region. South America has 
in general higher proportions of disability due to common 
mental illness; suicide imposes a disproportionately high 
burden on three subregional clusters: Suriname, Guyana, 
and Trinidad and Tobago; Uruguay, Chile, and Argentina; 
and Canada and the USA. Depressive disorders take their 
largest toll on young working-age populations. Continental 
Central America has a larger proportion of disability 
due to bipolar and childhood onset disorders than other 
subregions, as well as due to epilepsy; and the USA and 
Canada suffer a high disability toll from schizophrenia 
and dementia, as well as devastating rates of opioid-use 
disorder disability and premature death.
The health system’s response to the challenge of mental 
illness also shows regional variations, notably a correlation 
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with national income. Higher-income countries spend 
a larger share of their health budgets on mental health 
services, and appear to allocate their spending more 
efficiently, away from neuropsychiatric hospitals, towards 
integration of mental health into primary care and 
community resources. Conversely, lower-income settings 
seem to compound their lack of resources by allocating 
them to specialized neuropsychiatric hospitals instead of 
funding community and primary mental health services, a 
strategy that would target not only the increasing disability 
resulting from depression and common mental illness, 
but also the amenable mortality resulting from severe 
mental illness, largely due to treatable causes that remain 
uncared for due to stigma, lack of community support, and 
insufficiently integrated health services. The imbalance 
between the burden and the effectively allocated mental 
health services is appalling, ranging from 3 times in the 
United States and Canada to 435 times in Haiti, with a 
regional median of 32. This government spending gap, 
which disproportionally affects lower-income countries, 
can be expected to result in (a) undertreatment and 
increased amenable disability and mortality; and (b) 
increased out-of-pocket spending resulting in potentially 
catastrophic health spending, and decreased productivity 
both at the individual and national level.
In summary, MNSS is a group of diseases and conditions 
that are a major cause of disability and mortality, and 
give rise to a third of total YLDs and a fifth of total 
DALYs in the Americas; furthermore, mental health 
is increasingly acknowledged as a global health and 
economic development priority. Indeed, the United 
Nation’s Sustainable Development Goals explicitly refer 
to universal health coverage inclusive of mental health 
and well-being as a global commitment. It is imperative 
that Governments—especially of low- and middle-
income countries (LAMICS)—reconsider how their health 
budgets are allocated. Instead of yielding to the inertia of 
minimal—usually reactive—adjustments to last year’s line-
item budgets, they can take bold steps to purposefully 
allocate funds following a rational assessment of needs, 
priorities, available resources, and existing evidence. 
Despite the obvious constraints that health and mental 
health budgets have in LAMICS, there is significant room 
to make meaningful improvements. In fact, it is precisely 
because of these constraints that effective and cost-
effective use of resources is of paramount importance. 
Rather than allocating the lion’s share to specialized 
hospitals, countries should prioritize funding community 
and primary mental health services, following a balanced 
care strategy that would target the multiple sources of 
disease burden resulting from mental disorders: mood 
disorders and suicide; substance use disorders and death 
by overdose or alcohol-related accidents and illnesses; 
and, finally, the increased mortality resulting from 
severe mental illness due to treatable causes that are 
ineffectively cared for due to stigma, lack of community 
support, and poorly integrated health services.
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Annex 1
Non-Latin Caribbean Subregion Countries and Population
Country
Antigua and Barbuda 91,861
Barbados 283,841
Belize 358,715
Bermuda 66,868
Dominica 71,672
Grenada 106,968
Guyana 770,068
Jamaica 2,823,613
Saint Lucia 185,108
Saint Vincent and the Grenadines 109,755
Suriname 542,588
Virgin Islands, U.S. 106,626



